Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study

Atsumi, 1999, Risk factors for vertebral fractures in renal osteodystrophy, Am J Kidney Dis, 33, 287, 10.1016/S0272-6386(99)70302-1 Young, 2000, The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study, Kidney Int, 57, S74, 10.1046/j.1523-1755.2000.07413.x Goodkin, 2003, Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States in the Dialysis Outcomes and Practice Patterns Study (DOPPS), J Am Soc Nephrol, 14, 3270, 10.1097/01.ASN.0000100127.54107.57 Rayner, 2004, Mortality and hospitalisation in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Nephrol Dial Transplant, 19, 108, 10.1093/ndt/gfg483 K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. www.kidney.org/professionals/kdoqi/guidelines bone/index.htm Kessler, 2002, The EBPG Expert Group on Haemodialysis. European best practice guidelines for haemodialysis (Part 1), Nephrol Dial Transplant, 17, 1 Hsu, 1997, Are we mismanaging calcium and phosphate metabolism in renal failure?, Am J Kidney Dis, 29, 641, 10.1016/S0272-6386(97)90352-8 Block, 1998, Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study, Am J Kidney Dis, 31, 607, 10.1053/ajkd.1998.v31.pm9531176 Goodman, 2000, Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis, N Engl J Med, 342, 1478, 10.1056/NEJM200005183422003 Tokuyama, 2002, Conjunctival and corneal calcification and bone metabolism in hemodialysis patients, Am J Kidney Dis, 39, 291, 10.1053/ajkd.2002.30548 Raggi, 2002, Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?, J Am Coll Cardiol, 39, 695, 10.1016/S0735-1097(01)01781-8 Chertow, 2002, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients, Kidney Int, 62, 245, 10.1046/j.1523-1755.2002.00434.x Ganesh, 2001, Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients, J Am Soc Nephrol, 12, 2131, 10.1681/ASN.V12102131 Teng, 2003, Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy, N Engl J Med, 349, 446, 10.1056/NEJMoa022536 Port, 2003, Random samples (DOPPS) versus census-based (registry) approaches to kidney disease research, Blood Purif, 21, 85, 10.1159/000067859 Foley, 1996, Hypocalcemia, morbidity, and mortality in end-stage renal disease, Am J Nephrol, 16, 386, 10.1159/000169030 Gupta, 2000, Race is a major determinant of secondary hyperparathyroidism in uremic patients, J Am Soc Nephrol, 11, 330, 10.1681/ASN.V112330 Sawaya, 2002, Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism, Clin Nephrol, 57, 51, 10.5414/CNP57051